The number of people with susceptibility test result for rifampicin in Sudan
Sudan: The number of people with susceptibility test result for rifampicin was 79.91 in 2021. ◆ Volatile
Latest (2021)
79.91
Change on year
up 22.8%
World rank
96th
of 146 countries
All-time high
79.91
in 2021
All-time low
4.29
in 2017
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Sudan, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
Sudan recorded 79.91 for the number of people with susceptibility test result for rifampicin in 2021. That is the highest value across all 5 years on record.
Compared with earlier readings it is up 22.8% on the previous year and up 1,762.4% over five years.
That places Sudan 96th out of 146 countries with data for 2021, putting it in the middle of the range.
The number of people with susceptibility test result for rifampicin in Sudan, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 4.29 | — |
| 2018 | 19.66 | +358.2% |
| 2019 | 51.02 | +159.5% |
| 2020 | 65.07 | +27.5% |
| 2021 | 79.91 | +22.8% |
Sudan compared with similar countries
- Sudan's 79.91 is above the median for low income countries, which is 37.16, 2.2× the median. (13 countries reporting)
- Sudan's 79.91 is above the median for Sub-Saharan Africa, which is 61.16, 1.3× the median. (32 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 24.99 | 4.29 | 51.02 | 3 |
| 2020s | 72.49 | 65.07 | 79.91 | 2 |
Countries ranked near Sudan
More health data for Sudan
- Un projection of annual infant deaths, annual growth rate -1.63 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.6701 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 841.3 deaths per 1,000 people (2090)
- Number of infants who die before age 1 14,804 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 22 (2025)
- Population ages 00-04, female, annual growth rate 1.27 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0737 units per person (2025)
- Population ages 00-04, male, annual growth rate 1.15 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0.0001 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Sudan?
- The number of people with susceptibility test result for rifampicin in Sudan was 79.91 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Sudan?
- The highest recorded value was 79.91 in 2021.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Sudan?
- The lowest recorded value was 4.29 in 2017.
- How does Sudan rank for the number of people with susceptibility test result for rifampicin?
- Sudan ranks 96th out of 146 countries with data for 2021.
- Where does this Sudan data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).